









市場
/
株式
/
nasdaq-qtrx
/

Quanterix Corp

QTRX

6.010USD

+0.150+2.56%

取引時間（ET）15分遅れの株価

233.19M時価総額

損失額直近12ヶ月PER



Quanterix Corp

6.010

+0.150+2.56%

概要企業名金融

Quanterix Corporation is a life sciences company. The Company is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to detect protein biomarkers in low concentrations in blood, serum, and other fluids. The Company's Simoa technology is based on traditional enzyme-linked immunosorbent assay (ELISA) technology. Its products include HD-X, SR-X, SP-X, Simoa assays and consumables, and NfL antibodies and NfL ELISA kits. It also offers contract research services for customers through its Accelerator Laboratory, which provides customers with access to Simoa technology and supports multiple projects and services, including sample testing, homebrew assay development and custom assay development. It has completed over 2,200 projects for 480 customers using its Simoa platforms.

企業情報

企業コードQTRX

会社名Quanterix Corp

上場日Dec 07, 2017

最高経営責任者「CEO」Dr. Masoud Toloue, Ph.D.

従業員数471

証券種類Ordinary Share

決算期末Dec 07

本社所在地900 Middlesex Turnpike

都市BILLERICA

証券取引所NASDAQ Global Market Consolidated

国United States of America

郵便番号01821

電話番号16173019400

ウェブサイトhttps://www.quanterix.com/

企業コードQTRX

上場日Dec 07, 2017

最高経営責任者「CEO」Dr. Masoud Toloue, Ph.D.

役員一覧

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

Mr. Jeffrey Thomas (Jeff) Elliott

Independent Director

19.42K

+62.04%

Ms. Vandana Sriram, CPA

Chief Financial Officer, Treasurer

9.28K

-2.41%

Dr. Ivana Magov Evi-liebisch, J.D., Ph.D.

Independent Director

Mr. Paul M. Meister

Independent Director

会社名

会社名/ポジション

ポジション

株式保有

変動額

Dr. David R. Walt, Ph.D.

Independent Director

1.86M

+0.12%

Dr. Masoud Toloue, Ph.D.

President, Chief Executive Officer, Director

278.40K

-0.44%

Mr. William P. (Bill) Donnelly

Independent Chairman of the Board

130.34K

+3.33%

Mr. Scott Mendel

Director

28.65K

Dr. Myla P. Lai-Goldman, M.D.

Director

27.40K

Ms. Karen A. Flynn

Independent Director

26.41K

+20.04%

収益内訳

通貨: USD更新時刻: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q2

FY2024Q1

FY2023

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

事業別USD

会社名

収益

比率

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

地域別USD

会社名

収益

比率

North America

19.38M

64.01%

EMEA

6.63M

21.92%

Asia Pacific

4.26M

14.07%

事業別

地域別

事業別USD

会社名

収益

比率

Product revenue

20.74M

68.51%

Service and other revenue

8.76M

28.95%

Collaboration and license revenue

771.00K

2.55%

株主

更新時刻: Sat, Aug 2

株主統計

種類

株主統計

比率

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

株主統計

比率

Columbia Threadneedle Investments (UK)

6.49%

Portolan Capital Management, L.L.C.

6.41%

BlackRock Institutional Trust Company, N.A.

5.81%

The Vanguard Group, Inc.

5.47%

Kent Lake PR LLC

4.52%

Other

71.29%

種類

株主統計

比率

Investment Advisor/Hedge Fund

30.87%

Investment Advisor

25.39%

Hedge Fund

12.76%

Individual Investor

6.60%

Research Firm

3.49%

Pension Fund

0.35%

Bank and Trust

0.21%

Family Office

0.13%

Venture Capital

0.05%

Other

20.15%

機関投資家保有株

更新時刻: Tue, Jul 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q2

391

37.62M

83.70%

-11.91M

2025Q1

401

40.45M

104.19%

-6.42M

2024Q4

388

38.02M

98.63%

-6.28M

2024Q3

386

36.47M

95.03%

-5.94M

2024Q2

394

35.66M

93.20%

-9.57M

2024Q1

395

35.56M

93.43%

-9.17M

2023Q4

388

34.77M

91.99%

-10.35M

2023Q3

382

36.53M

97.35%

-9.84M

2023Q2

388

36.74M

98.24%

-9.95M

2023Q1

389

37.25M

100.03%

-8.36M

詳細を見る

株主動向

会社名

保有株式数

比率

変動額

変動率

日付

Columbia Threadneedle Investments (UK)

3.00M

7.72%

+237.57K

+8.60%

Mar 31, 2025

Portolan Capital Management, L.L.C.

2.96M

7.63%

+375.57K

+14.51%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

2.68M

6.91%

-89.03K

-3.21%

Mar 31, 2025

The Vanguard Group, Inc.

2.53M

6.5%

+316.41K

+14.32%

Mar 31, 2025

Kent Lake PR LLC

2.92M

7.53%

+279.82K

+10.58%

Mar 31, 2025

Walt (David R)

1.86M

4.79%

+370.00K

+24.84%

Jun 13, 2025

William Blair Investment Management, LLC

1.11M

2.85%

+43.96K

+4.14%

Mar 31, 2025

UBS Financial Services, Inc.

1.11M

2.87%

+186.90K

+20.14%

Mar 31, 2025

Easterly Investment Partners LLC

1.33M

3.41%

+370.63K

+38.81%

Mar 31, 2025

Invenomic Capital Management LP

902.04K

2.32%

+546.67K

+153.83%

Mar 31, 2025

詳細を見る